Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Vertex Pharmaceuticals Incorporated”

980 pharma patents match "Vertex Pharmaceuticals Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 980
Index total 30,257
Page 18 / 41

Quick answer

This filtered view shows 980 pharmaceutical patents matching "Vertex Pharmaceuticals Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

980 results for “Vertex Pharmaceuticals Incorporated” · 30,257 patents in full index Clear search

  1. US 8598164

    Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted
  2. US 8598181

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted
  3. US 8598361

    Process for preparing 5-fluoro-1H-pyrazolo [3,4-B] pyridin-3-amine and derivatives therof

    Vertex Pharmaceuticals Incorporated · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted
  4. US 8598205

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted
  5. US 8592602

    Processes for producing cycloalkylcarboxamido-pyridine benzoic acids

    Vertex Pharmaceuticals Incorporated · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted
  6. US 8592577

    Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted
  7. US 8586615

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Nov 19, 2013 · Expires Nov 14, 2033

    granted
  8. US 8586589

    Piperidine and piperazine phenyl sulfonamides as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Nov 19, 2013 · Expires Nov 14, 2033

    granted
  9. US 8580802

    Pyrrolo[2,3-D]pyrimidines as inhibitors of Janus kinases

    Vertex Pharmaceuticals Incorporated · Granted Nov 12, 2013 · Expires Nov 7, 2033

    granted
  10. US 8575208

    Inhibitors of serine proteases

    Vertex Pharmaceuticals Incorporated · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted
  11. US 8575209

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted
  12. US 8569337

    Tri-cyclic pyrazolopyridine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 29, 2013 · Expires Oct 24, 2033

    granted
  13. US 8563593

    Formulations of (R)-1-(2,2-difluorobenzo[D] [1,3] dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide

    Vertex Pharmaceuticals Incorporated · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted
  14. US 8563576

    Tri-cyclic pyrazolopyridine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted
  15. US 8563573

    Azaindole derivatives as CFTR modulators

    Vertex Pharmaceuticals Incorporated · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted
  16. US 8557818

    Compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted
  17. US 8557833

    Aminopyrimidines useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted
  18. US 8552034

    Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof

    Vertex Pharmaceuticals Incorporated · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  19. US 8552006

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  20. US 8546414

    Ion channel modulators and methods of use

    Vertex Pharmaceuticals Incorporated · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted
  21. US 8541445

    Pyrazolopyridines

    Vertex Pharmaceuticals Incorporated · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted
  22. US 8541453

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted
  23. US 8541025

    Co-crystals and pharmaceutical formulations comprising the same

    Vertex Pharmaceuticals Incorporated · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted
  24. US 8536195

    Bicyclic derivatives as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted